Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/10/2012CN101560175B Thiourea derivatives and preparation method and use thereof
10/10/2012CN101553478B Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
10/10/2012CN101536980B Rubescensin preparation and preparation method and use of same
10/10/2012CN101531570B 1,2-substituted-5-acetylenyl-(or 10,11-dihydro)-5H-diphenyl[a,d] suberne (alkyl)-5-alcohol, synthesizing method and application
10/10/2012CN101528211B Ophthalmic percutaneous absorption type preparation
10/10/2012CN101525360B Hydrates of macrolides organic acid salts, preparation and application thereof
10/10/2012CN101506139B Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
10/10/2012CN101501032B Fused, tricyclic sulfonamide as inhibitors of gamma secretase
10/10/2012CN101495517B Low molecular weight heparin composition and uses thereof
10/10/2012CN101490064B Novel glucokinase activators and methods of using same
10/10/2012CN101479249B Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
10/10/2012CN101472921B Pyridylisoxazole derivative
10/10/2012CN101472572B Use of a RAR antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects
10/10/2012CN101455661B Use of 3-substituted phthalide and the analogue
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101443006B Novel benzylamine derivatives as CETP inhibitors
10/10/2012CN101437835B Short interference ribonucleic acids molecule for treating allergic diseases
10/10/2012CN101437394B Cationic antiseptic compositions and methods of use
10/10/2012CN101411779B Chinese medicine effective component composition for treating liver cancer and method for preparing the same
10/10/2012CN101405285B Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and P53
10/10/2012CN101405031B Formulations for parenteral delivery of compounds and uses thereof
10/10/2012CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity
10/10/2012CN101370796B Thiazoles as 11 beta-HSD1 inhibitors
10/10/2012CN101370784B Compound serving as ERK inhibitors
10/10/2012CN101341125B New phenanthridine derivatives as bradykinin antagonists
10/10/2012CN101309689B Dipeptidyl peptidase inhibitors for treating diabetes
10/10/2012CN101274932B 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof
10/10/2012CN101273984B Use of flavone compounds as potassium channel inhibitors
10/10/2012CN101263112B Histamine H3 receptor agents, preparation and therapeutic uses
10/10/2012CN101248105B Polymer conjugates of K-252a and derivatives thereof
10/10/2012CN101247805B Tablet containing hardly soluble active ingredient
10/10/2012CN101244064B Pharmaceutical combination for preventing and treating motion sickness and preparations thereof
10/10/2012CN101229127B Liposome preparation
10/10/2012CN101228161B Pyrrolopyridines useful as inhibitors of protein kinase
10/10/2012CN101228132B Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors
10/10/2012CN101223184B Glucuronidated nebivolol
10/10/2012CN101217982B Drug-containing photocrosslinked hyaluronic acid derivative gel
10/10/2012CN101180048B Amino acid composition for improving glucose tolerance
10/10/2012CN101142194B Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
10/10/2012CN101137356B Adhesive and plaster
10/10/2012CN101137355B Non-fibrous transdermal therapeutic system and method for its production
10/10/2012CN101133043B Method of producing proanthocyanidin oligomer
10/10/2012CN101129368B Freeze-dried powder needle containing lansoprazole
10/10/2012CN101115765B Modified 5'-phosphonates of azt potential antiviral drugs
10/10/2012CN101098623B Application of antioxidant for gene adjustment
10/10/2012CN101083907B Compositions and methods for topical diagnostic and therapeutic transport
10/10/2012CN101077867B Bis-aryl sulfonamides
10/10/2012CN101023074B Inhibitors of the interaction between MDM2 and P53
10/10/2012CN101018772B Neurologically-active compounds
10/10/2012CN101001863B Tanaproget derivatives, metabolites, and uses thereof
10/09/2012USRE43728 Thiazolidin-4-one derivatives
10/09/2012US8283479 CXCR2 inhibitors
10/09/2012US8283477 Method for preparing N-substituted maleimides
10/09/2012US8283475 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
10/09/2012US8283474 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
10/09/2012US8283471 Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline
10/09/2012US8283470 Method for the preparation of solifenacin and intermediate thereof
10/09/2012US8283454 Processes for the preparation of SGLT2 inhibitors
10/09/2012US8283383 Biphenyl amides as P2X3 and P2X2/3 antagonists
10/09/2012US8283382 Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
10/09/2012US8283381 Conjugated psychotropic drugs and uses thereof
10/09/2012US8283380 Methods for treatment of parkinson's disease
10/09/2012US8283379 Methods and compositions for the treatment of CNS-related conditions
10/09/2012US8283378 Phenylurea inhibitors of the SOAT-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
10/09/2012US8283377 Method for inhibiting blood vessel stenosis
10/09/2012US8283376 Use of substituted 2-aminotetralins for preventive treatment of parkinson's disease
10/09/2012US8283375 2, 6 xylidine derivatives for the treatment of pain
10/09/2012US8283374 Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
10/09/2012US8283373 Inhibitors of cytosolic phospholipase A2
10/09/2012US8283372 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
10/09/2012US8283371 Compounds
10/09/2012US8283370 Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
10/09/2012US8283369 Compounds and compositions and methods of use
10/09/2012US8283368 Selective ligands for the dopamine 3 (D3) receptor and methods of using the same
10/09/2012US8283367 Proteasome inhibitors and methods of using the same
10/09/2012US8283366 Derivatives of pyridoxine for inhibiting HIV integrase
10/09/2012US8283365 Indole modulators of the alpha 7 nicotinic acetylcholine receptor
10/09/2012US8283364 Psyvhological disorders; cognition activators
10/09/2012US8283363 Carboxamide compounds and their use as calpain inhibitors
10/09/2012US8283362 Beta-2-adrenoreceptor agonists
10/09/2012US8283361 Heterocyclic urea derivatives and methods of use thereof
10/09/2012US8283360 Bicyclic heterocyclic derivatives and methods of use thereof
10/09/2012US8283359 Thieno-pyridine derivatives as MEK inhibitors
10/09/2012US8283358 N-sulfonamido polycyclic pyrazolyl compounds
10/09/2012US8283357 Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
10/09/2012US8283356 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors
10/09/2012US8283355 Pyrimidine derivatives as POSH and POSH-AP inhibitors
10/09/2012US8283354 Quinazolines useful as modulators of ion channels
10/09/2012US8283353 Fused ring compound and use thereof
10/09/2012US8283352 Solubilization preparation
10/09/2012US8283351 Inhibiting cyctic fibrosis transmembrane conductance regulator polypeptide ; therapy for diarrhea and polycystic kidney disease
10/09/2012US8283350 Compositions and methods for reducing capillary permeability
10/09/2012US8283349 Fungicide N-(3-phenylpropyl) carboxamide derivatives
10/09/2012US8283348 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
10/09/2012US8283347 Redox molecules and methods of making the same
10/09/2012US8283346 Human immunodeficiency virus protease inhibitors
10/09/2012US8283345 Azetidine analogues of nucleosidase and phosphorylase inhibitors
10/09/2012US8283344 Method of treating inherited severe neutropenia
10/09/2012US8283343 Ansamycin formulations and methods of use thereof
10/09/2012US8283342 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
1 ... 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 ... 7860